U.S. Markets closed

Depomed, Inc. (DEPO)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.55+0.25 (+3.97%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close6.30
Bid6.45 x 200
Ask10.64 x 500
Day's Range6.16 - 6.63
52 Week Range5.88 - 27.02
Avg. Volume1,785,912
Market Cap412.4M
PE Ratio (TTM)-4.26
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • See what the IHS Markit Score report has to say about Depomed Inc.
    Markit4 days ago

    See what the IHS Markit Score report has to say about Depomed Inc.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • Thomson Reuters StreetEvents8 days ago

    Edited Transcript of DEPO earnings conference call or presentation 7-Aug-17 8:30pm GMT

    Q2 2017 Depomed Inc Earnings Call

  • Depomed, Inc. – Value Analysis (NASDAQ:DEPO) : August 11, 2017
    Capital Cube9 days ago

    Depomed, Inc. – Value Analysis (NASDAQ:DEPO) : August 11, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Depomed, Inc. a score of 28. Our analysis is based on comparing Depomed, Inc. with the following peers – BioDelivery Sciences International, Inc., Ironwood Pharmaceuticals, Inc. Class A, Mallinckrodt Plc, Insys Therapeutics, Inc., Pfizer Inc., Cara Therapeutics Inc, Galena Biopharma, Inc., Merck & Co., Inc. and Johnson ... Read more (Read more...)